Cancer Vaccines | A survivors story|From Cancer Good Things Grow Grace Gawler

I encored a recent interview with Jeffery Deslandes on my Voice America Internet radio show today for the Christmas period for a special reason. Because his story is both true and inspirational.

I encored a recent interview with Jeffery Deslandes on my Voice America Internet radio show today for the Christmas period for a special reason. Because his story is both true and inspirational. As Jeffrey quotes in his recently released ;  book; “From Cancer Good Things Grow”;  there are about 4,000 new cases of NHL each year in Australia. 1600 Australian die from NHL each year. If this were our road toll and there was an effective way of preventing deaths of even half of that number – there would be campaigns and lots of public and political interest. Why is there such little  interest in cancer immunotherapies? Jeffrey Deslandes is just one of many who have had success with vaccine treatments.

The questions begs – Have we become so conditioned to believing that cancer is a one-way ticket and there’s nothing we can do apart from try alternative medicine and throw out the “conventional medicine” baby with the bathwater?  Have we been convinced that conventional cancer medicine doesn’t work and that all big Jeffrey Deslandes Book 001pharma wants you to do is stay sick to garnish the pockets of doctors?  Have we bought into the rumour that the war on cancer is lost?  These are common statements from the Google cancer entrepreneurs whose aim is to convince patients to follow them, buy their “one size fits all” cancer products and……… take no responsibility for patient outcomes.

I know of far too many  patients who are not here to be with their families this Christmas because they used “faceless” advice from books, CDs or the internet – leaving aside treatable and potentially curable treatments for their cancer until it became obvious that their attempts to replicate the “cures” they have read about; ultimately failed them. This year I have experienced a new phenomenon, receiving many emails from parents who have taken the natural cancer “healing” path with their children using bizarre nutritional regimens, GcMAF, Budwig and Gerson Diets to name a few – most read about these treatments on blogs. Some of these children have been 3 and 5 years of age.  I try my best to influence them towards excellent sources of conventional medicine – but after a few emails – I never hear from them again. This is truly exasperating!!

Genuine, well documented  stories of cancer treatment successes are much needed. Such is the story of how Melbournian Jeffery Deslandes recovered from Stage 4 recurrent lymphoma that had grown resistant to conventional treatment found his remission – now eight and a half years clear. Jeffery did not seek Alternative medicine treatments when his lymphoma recurred again and again; rather he looked outside the conventional box to see what else science-based medicine could offer.

By purchasing Jeffrey Deslandes book (soft Cover /eBook) – you can help to promote the immune therapy he had right here in Australia. All proceeds go toward making this treatment more available for those in our region. PLEASE spread the good news. Vaccine therapies as immunotherapies go wider than just lymphoma. Successes are appearing from many cancer types including melanoma, prostate cancer and many more. If these therapies can be investigated alongside immune cycle research; we may indeed have a two incredibly power non invasive cancer treatment allies. Scroll to end of blog to see the effect of melanoma vaccine.**

Excerpts from Jeffrey Deslandes book “From Cancer Good things Grow”.

 

Chapter 7 -The cancer Returns Again and Again

Non-Hodgkin’s lymphoma is a bit like buffalo grass; it is hard to get out all of the roots and it tends to grow back. I had been informed that my cancer was incurable. It was a real shock at the time.
Non-Hodgkin’s lymphoma (NHL) is Australia’s fifth most common cancer, yet has a very low profile, compared to more publicised cancers such as breast, ovarian, bowel, melanoma and leukaemia. There are about 4,000 new cases of NHL each year in Australia, with about 1,600 deaths each year. That’s about the same as the National Road Toll in this country. Each year we spend billions trying to stop idiots killing each other on the road, yet comparatively little on a disease which is poorly understood. While Australia’s economy is soon to be taxed with the introduction of a Carbon Tax to combat Climate Change. Funny that, I have never known anyone who has died from Climate Change, but I have known scores and scores of people who have succumbed to cancer. We need Governments to spend serious money on cancer research.

After my cancer had returned for the fourth time in 2006, the next mainstream cancer treatment outlined by my specialist, was an autologous stem cell transplant. An autologous stem cell transplant, refers to your own body’s stem cells being first harvested, you are then given high-dose chemotherapy to hopefully kill all cancer in your body, and your stem cells

Jeffrey Deslandes
Jeffrey Deslandes

are then re-infused to build up your white cells, which have been decimated by the chemotherapy. The other option was an allogeneic stem cell transplant; the same procedure but the stem cells are used from a matched donor who is obviously free from cancer. However, for this we would need to find a matched donor, since my brother Ron was not a match, and other brother David was no longer with us. I decided not to take the recommendation of my highly trained lymphoma specialist. I decided that I would need to take charge of my treatment, and find something with a different mode of attack. If something is not working, you don’t keep hitting it with the same old stick! Read on,,,,,,,,

Chapter 8 – Vaccine Therapy–The New Beginning

Through my association with Lymphoma Australia, a fine not-for-profit organisation dedicated to raising awareness and supporting lymphoma patients, I became aware of work being done on vaccines for cancer treatment. This work was still experimental or being proven in clinical trials, but it was not quackery, it was being carried out by highly qualified haematologists and scientists.

My diseased lymph node, and my immature dendritic cells, were processed in the laboratory to manufacture a dendritic cell idiotype vaccine to fight the cancer. It is termed idiotype, because the vaccine is grown from my own cancer cells, and is thus specifically tailored to the idiosyncrasies of my cancer. It is worth noting that there are over 30 sub-types of lymphoma alone, and it is my understanding that each and every lymphoma is going to be somewhat different in its individual characteristics. By using my own lymphoma, we got a perfect match, the exact antibody to my cancer. The laboratory grew the vaccine formulation to make 33 doses of vaccine, which were stored at minus 196 °C in liquid nitrogen, and could be kept for perpetuity. Each dose of vaccine is about 1 ml, about a fifth of a teaspoon, but it contains about five million cells. Yes, that’s five million cells, each with a message for my immune system. The message was “this is what the cancer looks like, now do your job like you are supposed to, and go seek and destroy”.  Excerpt: “From Cancer Good Things Grow”

Help save a life ……… Readers of this blog – please help us to help others through cancer education. By passing on this blog or an episode from Voice America – you could also help cancer patients to re-frame their cancer experience and learn about the nature of cancer and how to outsmart it with science-based medicine.

May your Christmas season be filled with joy, love, passion and compassion….

Until next time….

Grace

**Warning:  Below – graphic image melanoma – positive results from repeated vaccine cancer treatments.

Conclusions: Prolonged, repetitive VMCL vaccination immunotherapy appears to be a clinically effective means
of generating relatively high CR rates, useful clinical responses and long-term survivals, with little toxicity, but
remains notably under-explored. Successive immunomodulation might explain the results. Closer analysis of
repetitive dosing is required.

Melanoma vaccines
Successful application of repeated dosing with Melanoma vaccines. Research- Brendon Coventry

Options, Choices and Treatments for Cancer Recovery| Navigating the Cancer Maze

New cancer treatments are always controversial; BUT – this method is not a treatment. It’s a smart approach. A Smart approach that utilizes all that we know so far about cancer. It works because ultimately; our innate immune system knows what to do.

Options, Choices and Treatments for Cancer Recovery: De mystifying the oscillating the immune cycle.

When my ex husband and I had the idea for starting support groups for cancer patients in the early 1980’s. cancer organizations, patients and doctors were initially not supportive. In fact they were skeptical. They could not see any possible therapeutic benefit could come from people attending a support group.  How wrong they were! Move forward Body rhythms diagram40 years! Yes this December marks my beginning working with cancer patients 40 years ago in a time when there was no support in the health system and no support groups. Now, the benefit of patients attending structured supports and the well being benefit is indisputable.

There are still many new areas to explore, which leads me to discussing the immune cycle. It would seem that during 2014 on Navigating the Cancer Maze – we uncovered and delivered some significant “missing” pieces of the cancer treatment puzzle. It is my hope that as 2014 comes to an end – that 2015 will truly usher in a new paradigm in cancer treatments. The foundation has been laid, extensive research already done, the concept has been introduced worldwide – the  immune cycle measurement is here – NOW!
Now it is up to cancer patients to prove Martin Ashdown and Brendon Coventry right….or wrong. I liked it when Martin Ashdown said – “We believe this is so, a breakthrough – but we are open to being proven wrong!” As in the early days of my first charitable  foundation – it was people power – patient power that made a difference to the success of the Cancer Support Group Movement. Once told there would likely be a measured benefit from attending a support group – the press broadcast the news and the patients came on board en masse!

New cancer treatments are always controversial; BUT – this method is not a treatment. It’s a smart approach. A Smart approach that utilizes all that we know so far about cancer. It works because ultimately; our innate immune system knows what to do. It is just in temporary overwhelm. So doesn’t it make perfect sense that to find the best time to work in synch within the cycle of each person’s immune system to add the best chemotherapy or monoclonal antibody or other targeted treatment. Isn’t this the personalized approach we have been searching for? We all thought it would come in a pill – not an approach and that’s a paradigm shift that some in the world of science and medicine are struggling with.

measuring immune cycleKnowing how one’s immune cycle oscillates holds a clue, “the missing link” that can direct doctors to seek the best time to treat patients in their personal window of opportunity. Then within the parameters of what we know they will have the best chance of a good response or complete response to treatment. (CR)

When cancer cells challenge us – they are also smart. They are a part of us created by our internal systems. You could define cancer as an internal systems error!  These cancer cells cleverly recruit our intelligent mechanisms using them for their own growth and survival. It seems a bit crazy that something that wants to survive – kills its host. But – that’s life! To listen to the latest Voice America related to this blog visit:
http://www.voiceamerica.com/episode/82056/options-choices-and-treatments-for-cancer-recovery

So – I believe as do Ashdown and Coventry – that if there is enough of the immune response left in a patient – that the cycle can still be measured and timed so administer the right treatment at the right time. It is simple enough – the only real cost being a series of blood tests. Then finding a doctor who will look at the science and research and say yes – they administer treatment during the 12 hour window of opportunity. The Grace Gawler Institute is keen to let you know and experience the immune cycle for yourself. Please Read more below or join the immune cycle registry at:

http://www.gracegawlerinstitute.com/immune-cycle-registry/ also see our Next “Survivor Academy” Course!

Martin Ashdown and Brendon Coventry have built upon earlier excellent work in the study of chronobiology: Below are references given on Navigating the Cancer Maze today: I have provided abstract content as well as links.

Until next time……Grace

  • Annu Rev Pharmacol Toxicol. 2010;50:377-421. doi: 10.1146/annurev.pharmtox.48.113006.094626.
    Circadian timing in cancer treatments.
    Lévi F1, Okyar A, Dulong S, Innominato PF, Clairambault J.
    Author information
    Abstract
    The circadian timing system is composed of molecular clocks, which drive 24-h changes in xenobiotic metabolism and detoxification, cell cycle events, DNA repair, apoptosis, and angiogenesis. The cellular circadian clocks are coordinated by endogenous physiological rhythms, so that they tick in synchrony in the host tissues that can be damaged by anticancer agents. As a result, circadian timing can modify 2- to 10-fold the tolerability of anticancer medications in experimental models and in cancer patients. Improved efficacy is also seen when drugs are given near their respective times of best tolerability, due to (a) inherently poor circadian entrainment of tumors and (b) persistent circadian entrainment of healthy tissues. Conversely, host clocks are disrupted whenever anticancer drugs are administered at their most toxic time. On the other hand, circadian disruption accelerates experimental and clinical cancer processes. Gender, circadian physiology, clock genes, and cell cycle critically affect outcome on cancer chronotherapeutics. Mathematical and systems biology approaches currently develop and integrate theoretical, experimental, and technological tools in order to further optimize and personalize the circadian administration of cancer treatments.
    PMID:
    20055686
    [PubMed – indexed for MEDLINE]
  • http://www.ncbi.nlm.nih.gov/pubmed/20055686

Ann Pharm Fr. 2008 Jun;66(3):175-84. doi: 10.1016/j.pharma.2008.05.003.
[The circadian-timing system: a determinant of drug activity and a target of anticancer treatments].
[Article in French]
Lévi F.
Author information
Abstract
Cellular proliferation and drug detoxification are controlled over the 24h by the circadian-timing system, whose disruption can favor malignant processes. Thus, prolonged shift work appears to increase the risk of breast, colon or prostate cancer. Alterations in circadian physiology and/or molecular-clock genes accelerate cancer progression in experimental models and in cancer patients. In addition, anticancer treatments can also dampen or reinforce the circadian-timing system, as a function of dose and time of administration. The adjustment of anticancer-drug delivery to the circadian-timing system (chronotherapeutics) has allowed to reduce five-fold the incidence of severe adverse events as compared to constant rate infusion or wrongly-timed chronomodulated delivery in cancer patients. In experimental models, the best antitumor efficacy is usually obtained following treatment delivery near the least toxic time, a statement that also seems to apply to patients. Dedicated technologies include programmable in time pumps and rhythm monitors and are required for chronotherapeutics. Recent results have revealed that the optimal chronotherapeutic schedule could differ as a function of gender and circadian physiology. In conclusion, the circadian-timing system was shown to negatively control malignant proliferation via partly identified molecular mechanisms. The components of the circadian-timing system thus constitute new potential therapeutic targets in oncology. Mathematical models help toward a better understanding of the role of variability for the determination of the optimal chronotherapeutic schedule and constitute useful tools for the personalization of cancer chronotherapeutics.

http://www.ncbi.nlm.nih.gov/pubmed/18706346

Handb Exp Pharmacol. 2013;(217):261-88. doi: 10.1007/978-3-642-25950-0_11.
Cancer chronotherapeutics: experimental, theoretical, and clinical aspects.
Ortiz-Tudela E1, Mteyrek A, Ballesta A, Innominato PF, Lévi F.
Author information
Abstract
The circadian timing system controls cell cycle, apoptosis, drug bioactivation, and transport and detoxification mechanisms in healthy tissues. As a consequence, the tolerability of cancer chemotherapy varies up to several folds as a function of circadian timing of drug administration in experimental models. Best antitumor efficacy of single-agent or combination chemotherapy usually corresponds to the delivery of anticancer drugs near their respective times of best tolerability. Mathematical models reveal that such coincidence between chronotolerance and chronoefficacy is best explained by differences in the circadian and cell cycle dynamics of host and cancer cells, especially with regard circadian entrainment and cell cycle variability. In the clinic, a large improvement in tolerability was shown in international randomized trials where cancer patients received the same sinusoidal chronotherapy schedule over 24h as compared to constant-rate infusion or wrongly timed chronotherapy. However, sex, genetic background, and lifestyle were found to influence optimal chronotherapy scheduling. These findings support systems biology approaches to cancer chronotherapeutics. They involve the systematic experimental mapping and modeling of chronopharmacology pathways in synchronized cell cultures and their adjustment to mouse models of both sexes and distinct genetic background, as recently shown for irinotecan. Model-based personalized circadian drug delivery aims at jointly improving tolerability and efficacy of anticancer drugs based on the circadian timing system of individual patients, using dedicated circadian biomarker and drug delivery technologies.
http://www.ncbi.nlm.nih.gov/pubmed/23604483

Chronobiol Int. 2002 Jan;19(1):1-19.
From circadian rhythms to cancer chronotherapeutics.
Lévi F.
Author information
Abstract
Mammalian circadian rhythms result from a complex organization involving molecular clocks within nearly all “normal” cells and a dedicated neuroanatomical system, which coordinates the so-called “peripheral oscillators.” The core of the central clock system is constituted by the suprachiasmatic nuclei that are located on the floor of the hypothalamus. Our understanding of the mechanisms of circadian rhythm generation and coordination processes has grown rapidly over the past few years. In parallel, we have learnt how to use the predictable changes in cellular metabolism or proliferation along the 24h time scale in order to improve treatment outcome for a variety of diseases, including cancer. The chronotherapeutics of malignant diseases has emerged as a result of a consistent development ranging from experimental, clinical, and technological prerequisites to multicenter clinical trials of chronomodulated delivery schedules. Indeed large dosing-time dependencies characterize the tolerability of anticancer agents in mice or rats, a better efficacy usually results from treatment administration near the least toxic circadian time in rodent tumor models. Programmable in time multichannel pumps have allowed to test the chronotherapy concepts in cancer patients and to implement chronomodulated delivery schedules in current practice. Clinical phase I and II trials have established the feasibility, the safety, and the activity of the chronotherapy schedules, so that this treatment method has undergone further evaluation in international multicenter phase III trials. Overall, more than 2,000 patients with metastatic disease have been registered in chronotherapy trials. Improved tolerability and/or better antitumor activity have been demonstrated in randomized multicenter studies involving large patient cohorts. The relation between circadian rhythmicity and quality of life and even survival has also been a puzzling finding over the recent years. An essential step toward further developments of circadian-timed therapy has been the recent constitution of a Chronotherapy cooperative group within the European Organization for Research and Treatment of Cancer. This group now involves over 40 institutions in 12 countries. It is conducting currently six trials and preparing four new studies. The 19 contributions in this special issue reflect the current status and perspectives of the several components of cancer chronotherapeutics.
PMID:
11962669
[PubMed – indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/pubmed/11962669
Cancer Causes Control. 2006 May;17(4):611-21.
Chronotherapeutics: the relevance of timing in cancer therapy.
Lévi F.
Author information
Abstract
BACKGROUND:
Cell physiology is regulated along the 24-h time scale by a circadian timing system composed of molecular clocks within each cell and a central coordination system in the brain. The mammalian molecular clock is made of interconnected molecular loops involving at least 12 circadian genes. The cellular clocks are coordinated by the suprachiasmatic nuclei, a hypothalamic pacemaker which also helps the organism adjust to environmental cycles. The rest-activity rhythm is a reliable marker of the circadian system function in both rodents and man. This circadian organization is responsible for predictable changes in the tolerability and efficacy of anticancer agents, and possibly also in tumor promotion or growth.
METHODS:
Expected least toxic times of chemotherapy were extrapolated from experimental models to human subjects with reference to the rest-activity cycle. The clinical relevance of the chronotherapy principle, i.e. treatment administration as a function of rhythms, has been demonstrated in randomized multicenter trials.
RESULTS:
Chronotherapeutic schedules have been used to safely document the activity of the association of oxaliplatin, 5-FU and leucovorin against metastatic colorectal cancer and to set up a new medicosurgical management of this disease which achieved unprecedented long term survival.
CONCLUSION:
The chronotherapy concept offers further promises for improving current cancer treatment options as well as for optimizing the development of new anticancer or supportive agents.
PMID:
16596317
[PubMed – indexed for MEDLINE]

Mol Med. 2012 Dec 6;18:1249-60. doi: 10.2119/molmed.2012.00077.
Circadian rhythm disruption in cancer biology.
Savvidis C1, Koutsilieris M.
Author information
Abstract
Circadian rhythms show universally a 24-h oscillation pattern in metabolic, physiological and behavioral functions of almost all species. This pattern is due to a fundamental adaptation to the rotation of Earth around its own axis. Molecular mechanisms of generation of circadian rhythms organize a biochemical network in suprachiasmatic nucleus and peripheral tissues, building cell autonomous clock pacemakers. Rhythmicity is observed in transcriptional expression of a wide range of clock-controlled genes that regulate a variety of normal cell functions, such as cell division and proliferation. Desynchrony of this rhythmicity seems to be implicated in several pathologic conditions, including tumorigenesis and progression of cancer. In 2007, the International Agency for Research on Cancer (IARC) categorized “shiftwork that involves circadian disruption [as] probably carcinogenic to humans” (Group 2A in the IARC classification system of carcinogenic potency of an agent) (Painting, Firefighting, and Shiftwork; IARC; 2007). This review discusses the potential relation between disruptions of normal circadian rhythms with genetic driving machinery of cancer. Elucidation of the role of clockwork disruption, such as exposure to light at night and sleep disruption, in cancer biology could be important in developing new targeted anticancer therapies, optimizing individualized chronotherapy and modifying lighting environment in workplaces or homes.
PMID:
22811066
[PubMed – indexed for MEDLINE]
PMCID:
PMC3521792
Free PMC Article

Chronobiol Int. 2012 Apr;29(3):227-51. doi: 10.3109/07420528.2012.658127.
Clock genes and clock-controlled genes in the regulation of metabolic rhythms.
Mazzoccoli G1, Pazienza V, Vinciguerra M.
Author information
Abstract
Daily rotation of the Earth on its axis and yearly revolution around the Sun impose to living organisms adaptation to nyctohemeral and seasonal periodicity. Terrestrial life forms have developed endogenous molecular circadian clocks to synchronize their behavioral, biological, and metabolic rhythms to environmental cues, with the aim to perform at their best over a 24-h span. The coordinated circadian regulation of sleep/wake, rest/activity, fasting/feeding, and catabolic/anabolic cycles is crucial for optimal health. Circadian rhythms in gene expression synchronize biochemical processes and metabolic fluxes with the external environment, allowing the organism to function effectively in response to predictable physiological challenges. In mammals, this daily timekeeping is driven by the biological clocks of the circadian timing system, composed of master molecular oscillators within the suprachiasmatic nuclei of the hypothalamus, pacing self-sustained and cell-autonomous molecular oscillators in peripheral tissues through neural and humoral signals. Nutritional status is sensed by nuclear receptors and coreceptors, transcriptional regulatory proteins, and protein kinases, which synchronize metabolic gene expression and epigenetic modification, as well as energy production and expenditure, with behavioral and light-dark alternance. Physiological rhythmicity characterizes these biological processes and body functions, and multiple rhythms coexist presenting different phases, which may determine different ways of coordination among the circadian patterns, at both the cellular and whole-body levels. A complete loss of rhythmicity or a change of phase may alter the physiological array of rhythms, with the onset of chronodisruption or internal desynchronization, leading to metabolic derangement and disease, i.e., chronopathology.
PMID:
22390237
[PubMed – indexed for MEDLINE]

An Answer to Cancer – How Your Immune Body-Clock can assist Complete Remission | Navigating the Cancer Maze

Cancer affects everyone around the world in some way. Friends, relatives, children, mums and dads, grans and grandpas! It does not discriminate. It causes as much or perhaps even more misery than war because it reaches into every race, culture and country! If there was just one thing we could add to the recipe for Curing cancer or extending life with quality and well-being – wouldn’t we all be excited and interested?Do you want to know one important missing piece of the cancer puzzle? Two cancer researchers Martin Ashdown & Brendon Coventry have explored that question and yes they are excited!

How Your Immune Body-Clock can assist Complete Remission: (Please pass on the link to this blog to those in need)

Cancer affects everyone around the world in some way. Friends, relatives, children, mums and dads, grans and grandpas! It does not discriminate. It causes as much or perhaps even more misery than war because it reaches into every race, culture and country!  If there was just one thing we could add to the recipe for Curing cancer or extending life with quality and well-being – wouldn’t we all be excited and interested? Do you want to know one important missing piece of the cancer puzzle?  Listen to today’s show at: http://www.voiceamerica.com/episode/81479/an-answer-to-cancer-how-your-immune-body-clock-can-assist-complete-remission

Measuring immune cycles
Measuring immune cycles may be one missing piece of the cancer cure puzzle!

The show is free to air on the internet – live streaming listening at any time- free download – archived indefinitely.

Two cancer researchers Martin Ashdown & Brendon Coventry have explored that question and yes they are excited! So am I and so are some doctors and oncologists! Testing patients to map their immune cycle is not a complex exercise, but to do this, a system needs to be changed. All discoveries of worth seem to be hobbled for while – then accepted – struggling across the finish line…sometime after decades!

In 1983, Australian doctors J. Robin Warren and Barry Marshall isolated Helicobacter pylori, the bacterial cause of peptic ulcer disease. When the H. pylori hypothesis was developed, the doctors were certain that it would immediately gain universal acceptance and that within two years peptic ulcer therapy would be essentially an antimicrobial regimen”. This was far from the case. A 1986 book on Peptic Ulcer and its Drug Causation lends a page to the bacterial hypothesis, noting, “Whether these bacteria have an aetiological role in peptic ulcer gastritis is unknown”. At this time, doctors still prescribed drugs to reduce stomach acidity and monitored patients for complications. The story of Helicobacter pylori’s acceptance as a pathogenic agent reveals the issues with the acceptance of new thought even when there is validation and justification. http://www.jyi.org/issue/delayed-gratification-why-it-took-everybody-so-long-to-acknowledge-that-bacteria-cause-ulcers/

There are ethical laws in place; essential for the safety of humans in medicine. Changed laws of medical ethics, prevent a modern reprise of Pasteur’s heroic demonstration of his rabies vaccine through the vaccination of an infected boy. Measuring each cancer patients immune cycle and timing their treatment at the right time –  is nothing akin to that! It simply makes sense!

Perhaps one can understand the caution in prescribing an antibiotic. Measuring immune cycles and timing treatment for a better outcome? Now to my way of thinking this fulfills the old Hippocratic oath – “Above all, do no harm!”

The Grace Gawler Institute has a history of wanting to procure the best treatment options for cancer patients. We feel that by educating patients about their immune cycle and taking this material to their doctor – they can help change the face of cancer treatment in a risk free experiment to prove (or not) the research work of Martin Ashdown & Brendon Coventry.  This is why we have created the Cancer Immune Registry:

world cancer
Cancer affects everyone around the globe- it does not discriminate!

Background –  A cancer drug used for more than 20 years that is now providing oncologists with new information about how to best help patients achieve complete remission. The drug called interleukin-2, is providing cancer researchers with something akin to how the “Rosetta Stone” was used to unlock historical script; the outcome; mapping the immune cycle!

To understand how this is possible – join me with guest Martin Ashdown on Navigating the Cancer Maze on Voice America’s Health and Wellness channel ( internet radio)  to hear the full story of this amazing breakthrough.

Learn how you can access info about your immune cycle to assist cancer treatment efficacy.

RESOURCES:

1. http://www.voiceamerica.com/episode/81479/an-answer-to-cancer-how-your-immune-body-clock-can-assist-complete-remission

2. http://www.gracegawlerinstitute.com/immune-cycle-registry/

3. Martin Ashdown Window of Opportunity1 article: Australasian Science

4. MARTIN ASHDOWN A Matter of Time_AS_Article: article Australasian Science

5. VIDEO: Treatment of Metastatic Melanoma: Could Timing Be Everything? http://www.youtube.com/watch?v=yXX-9t8xiAo

6. CLICK  HERE FOR PRESS RELEASE VOICE AMERICA

7. CLICK HERE FOR VOICEAMERICA PRESS PASS RELEASE

Grace Gawler|What you Need to Know to Safely Navigate the Complementary Medicine Maze

With 30 years experience as a botanical medicine practitioner, I know that complementary medicines are very popular with cancer patients. Some believe they are an alternative to conventional medicine, rather than a complement or adjunct to other treatments. Patients tend not disclose natural medicines they are taking when seeing their oncologist. Some oncologists don’t ask. Some patients take an each way bet and use both conventional and “natural medicines”, but in most cases; they will likely never tell their doctor what they are doing.

Grace Gawler | What you Need to Know to Safely Navigate the Complementary Medicine Maze – October 31, 2014

LISTEN TO TODAY"S VOICE AMERICA AUDIO - GRACE GAWLER
CLICK HERE FOR TODAY”S VOICE AMERICA AUDIO – GRACE GAWLER

Today’s Navigating the cancer Maze will give insights With 30 years experience as a botanical medicine practitioner, I know that complementary medicines are very popular with cancer patients. Some believe they are an alternative to conventional medicine, rather than a complement or adjunct to other treatments. Patients tend not disclose natural medicines they are taking when seeing their oncologist. Some oncologists don’t ask. Some patients take an each way bet and use both conventional and “natural medicines”, but in most cases; they will likely never tell their doctor what they are doing. Why? Because they expect a prejudiced attitude, either ridiculing their choice or telling them to stop everything else they are taking or doing that is not considered real medicine. Herein lies an enormous modern-day dilemma because many alternative & complementary medicines are indeed REAL medicines with active phyto-chemical contents.In today’s episode and on this blog – I also share useful information about Curcumin as a adjunct medicine for cancer patients.

 

First of all Vitamin C

I often see patients in my practice who refuse to have pharmaceutical drugs….they are often shocked when I explain to them that so called “natural medicines” they are using may not be natural at all – These substances actually become a drug or pharmaceutical product once they are administered by intravenous injection or intramuscular. It doesn’t mean they wont work – but the fact is they are NOT natural as is often marketed. They may have natural origins or have active principles of natural origin that has been synthesized in the laboratory.
Perhaps the best example here is vitamin C – there is no way we could use ascorbic acid as an i/v infusion….It must be modified in the laboratory.

  • Now this may come as a shock to those to love all things natural…..but Unfortunately, nearly all the dietary supplements marketed as vitamin C these days are synthetic isolates, made with genetically modified (GMO) corn from factories in China. Ascorbic acid is theoranges-and-lemons product most often paraded as “vitamin C,” but it’s really only a laboratory-produced synthetic “isolate”—meaning it is a single component of vitamin C. Mother Nature knew what she was doing when she created vitamin C-rich fruits, berries and plants. Scientists now know that vitamin C isolates such as ascorbic acid do not provide the health benefits that whole food forms of vitamin C do.

    This subject is so important that I will be inviting an expert on to the show soon to discuss the topic…. so sign up to receive an ecard notification for details of when this show will go to air.Join this blog to be updated and informed about complementary medicines and cancer – select Follow or join in the form in the widget bar on the right. The blog will be delivered weekly to your email address.

  • Curcumin – Tumeric

Multiple Molecular Targets of Curcumin
Curcumin attacks multiple targets, providing the scientific basis for its effectiveness in many different diseases. Extensive research shows most diseases are caused by dysregulation of multiple signaling pathways–casting doubt on the effectiveness of monotherapy, which is limited to a single target.
Studies show curcumin modulates numerous molecular targets, including: regulating several cytokines and fibroblast growth factor-2 (gene expression), growth-factor receptors including modulation of androgen receptors (protein kinases), transcription factors, pro-inflammatory enzymes (including supression of COX-2, 5-LOX and iNOS and regulation of NF-κB), modulation of cell-cycle-related gene expression, blocking the adhesion molecules, downregulating anti-apoptic proteins and inhibiting multi-drug resistance.

curcumin.2jpgCurcumin is the most important active ingredient in turmeric, and makes up about 2-6% of the spice.

While therapeutic properties of turmeric have been known for centuries, modern science has identified the curcuminoids (phenolic compounds found in turmeric) and provides a scientific basis for many clinical uses of standardized curcumin.

Since turmeric contains very small concentrations of curcumin, look for standardized 95% curcumin (curcuminoids). Why? Hundreds of scientific and technical papers confirm: clinical results were obtained using curcumin (curcuminoids).Most Curcumin Products Contain 3 Curcuminoids
Commercial curcumin typically contains curcumin I (~77%), curcumin II (~17%) and curcumin III (~3%) as its major components.
For convenience, all curcuminoids are often referred to simply as “curcumin” even though turmeric contains a variety of different curcuminoids. Unfortunately, pure curcumin (including all known curcuminoids) is very poorly absorbed into your bloodstream after oral ingestion due to rapid metabolism in the liver and intestinal wall, and rapid systemic elimination.

Many curcumin products add piperine to improve absorption of curcumin. But piperine is a problem for many consumers because the additive should be taken cautiously (if at all) by anyone taking medications. According to the American Society for Pharmacology and Experimental curcuminTherapeutics, piperine is a potent inhibitor of drug metabolism, which means piperine spikes blood levels of many prescription medications.
A review of published research articles reveals piperine is toxic in experimental animals. Some research suggests piperine is safe in small amounts but large amounts of piperine could be damaging to the liver or other organs. Experts advise against consuming more than 15 mg of piperine per day. Piperine has known central nervous system (CNS) depressant effects. Finally, since piperine is a component of black pepper, consumers with a known allergy or hypersensitivity to black pepper should avoid piperine.

Check out BIOMOR Cucumin       READ MORE at: http://curcumin-turmeric.net

 

ALSO HIGHLY RECOMMENDED: SEE DR LUDWIG JACOB’S: Curcumin K2

dr-jacobs-curcumin-k2-kapseln-60-stk

Available from Dr. Jacob’s Medical GmbH

Platter Str. 92

65232 Taunusstein

GERMANY            E-Mail: info@drjacobsmedical.de

Cheap versions of complementary medicines manufactured in countries with poor manufacturing and quality control standards are best avoided…….contamination is a big issue as well as growing, harvesting and all that happens to a the material before it gets to production. A recent example in May 2013 was the outbreak of symptomatic hepatitis A virus infections across 10 US states associated with pomegranate arils imported from Turkey and manufactured in the USA by an organic group. The source was traced to imported frozen pomegranate arils. These were identified as the vehicle early in the investigation by combining epidemiology—with data from several sources—genetic analysis of patient samples, and product tracing. There were 165 cases known to have been affected.Hepatitis A is spread when human feces contaminate food or when an infected food handler prepares food without using proper hygiene. Human feces are expected as the cause of the outbreak, according to the Wall Street Journal.

Remember – it’s best to ask for professional help when selecting products from the internet: Not only is it important to know the source of raw material – but the technique used in the manufacturing process and efficacy of the end product. Sometimes the pseudo-science that surrounds a product can be misleading.
Medicines and supplements purchased on the Interne need to be carefully scrutinized, especially if you are have cancer. Countries that have raw materials processed and manufactured with inadequate standards and poor quality control can be an issue.

Listen to today’s episode:Select the URL:

http://www.voiceamerica.com/episode/81372/what-you-need-to-know-to-safely-navigate-the-complementrary-medicine-maze

TO BE CONTINUED:

How Surgeons can Help you Navigate the Colorectal Cancer Maze | Dr Francis Seow Choen with Grace Gawler

Dr Francis Seow Choen is himself a medical miracle. As a 7 year old he recovered from major surgery for a cancer in his small intestine after facing a horrendous 6 months of radiation treatment and chemotherapy back in 1964 when treatments were harsh. He survived! Dr. Seow-Choen graduated from the National University of Singapore in 1981 & obtained his higher surgical qualifications in 1987. He sub-specialised in colorectal surgery in 1989 where he worked with the world-class surgeons of St Marks’ Hospital in London. He is a remarkable CR surgeon.

Part 2 – How Surgeons can Help you Navigate the Colorectal Cancer Maze

Dr Francis Seow Choen MBBS (Spore), FRCS (Edin), FAMS

Dr Francis Seow Choen Fortis Surgical Hospital Singapore
Dr Francis Seow Choen Fortis Surgical Hospital Singapore

Dr Francis Seow Choen is himself a medical miracle. As a 7 year old he recovered from major surgery for a cancer in his small intestine after facing a horrendous 6 months of radiation treatment and chemotherapy back in 1964 when treatments were harsh. He survived! Interview CLICK HERE

Dr. Seow-Choen graduated from the National University of Singapore in 1981 & obtained his higher surgical qualifications in 1987. He sub-specialised in colorectal surgery in 1989 where he worked with the world-class surgeons of St Marks’ Hospital in London. He is a remarkable CR surgeon.

I have interviewed Dr Francis Seow Choen previously on my internet radio show Navigating the Cancer Maze at Voice America. This time however, we touch on more details about the surgical techniques available for anyone dealing with colorectal cancer today.

As well, speaking as CR surgeon and recovered patient; he had a powerful message to cancer patients. Listen to this short excerpt from his interview: Select the icon below right to hear Dr Seow Choen’s message.

A personal message to cancer patients from Dr Francis Seow Choen
A personal message to cancer patients from Dr Francis Seow Choen

I have tremendous respect for the art and science of surgery. My own introduction to surgery came when I was 15 years of age. I began working in a veterinary clinic after school, then during holidays and for while as permanent staff. I was fortunate that the owner took me on as an apprentice as he knew my passion was to become a veterinarian. So, not only did I learn “hands-on” labrador retriever at the vetsurgery at an early age – I also was involved in co-performing post postmortems on animals which has served as a treasured learning field for understanding anatomy, physiology and pathology – many older dogs and cats who succumbed to an advanced and previously undiagnosed cancer that became a postmortem exercise; allowed me to see a wide range of cancers in vivo.

On the other hand, I was also impressed in how quickly animals responded to surgery for cancer and that for a high percentage of our animal clients – of those  caught early in diagnosis; few had a recurrence. There were also cases where enormous tumour loads were surgically removed, and the dog lived a long life afterwards! It was here that I developed a tremendous respect for surgical skills and the associated healing potential and regenerative powers that along with our animal friends, we all possess. However, surgery has come a long way since those days when robotic surgery entered the arena a few years ago.

You will find today’s interview with Dr Seow Choen informative, especially regarding the techniques using the new DaVinci Robotic surgery technology. You can read more about this technique as well as listening to the interview with Dr Seow Choen at: http://www.voiceamerica.com/episode/80875/how-surgeons-can-help-you-navigate-the-colorectal-cancer-maze-part-2

Singapore Fortis surgical Hospital da-Vinci-Robotic-Surgery equipment
Singapore Fortis surgical Hospital da-Vinci-Robotic-Surgery equipment

 

Dr. Seow-Choen helped establish the first colorectal surgery department in Asia at Singapore General Hospital (SGH) and is considered a leader in the development in CR surgery and approaches to treatment.

In this interview with Dr Seow Choen he also comments on diet and nutrition for cancer patients from the viewpoint of an experienced CR surgeon.

You may be surprised what he says……

 In the last segment of today’s show, I provide an overview on treatments available for CR cancer in 2014. A not to be missed show!

DaVinci robotic surgery technology
DaVinci robotic surgery technology

Resources:

Contact: www.fortissurgicalhospital.com to learn more…..

Or visit Dr Seow Choen’s website:

http://www.colorectalcentre.com/eng/index.html 

Don’t miss reading the informative medical media articles  at……….

http://www.colorectalcentre.com/eng/media_articles.html

If you missed last weeks interview with Dr Seow Choen’s colleague Dr Lim Jit Fong –

CLICK HERE TO LISTEN

Remember all interviews on Navigating the Cancer Maze are free to air (on live streaming and available from the archives anytime) and can be downloaded for free on itunes.

The show is not copyright and is available to distribute in the interest of cancer education and public awareness.

The show is available globally and is sponsored by donations to the Grace Gawler Institute a registered NFP Health Promotion Charity with DGR status based in Australia with a global outreach.

Introducing Health Intelligence Australia-A new Model of Healthcare Grace Gawler and Dr Bruce Whelan

On this week’s Navigating the Cancer Maze on Voice America radio, I presented an encore broadcast of a special interview with my colleague GP Dr Bruce Whelan: “Spinning Gold from Straw: How trauma transformed a Doctor’s Life and Practice”. This year, Dr Whelan and I have forged a very special medical partnership to help patients Navigate the Cancer Maze – Health Intelligence Australia.

On this week’s Navigating the Cancer Maze  on Voice America radio, I presented an encore broadcast of a special interview with my colleague GP Dr Bruce Whelan: “Spinning Gold from Straw: How trauma transformed a Doctor’s Life and Practice”. This year, Dr Whelan and I have forged a very special medical partnership to help patients Navigate the Cancer Maze – Health Intelligence Australia.
Last week a patient asked me what makes Dr. Bruce Whelan unique in terms of the type of medicine he practises? The answer came Health intelligence australiaeasily. In the past 10 years Bruce has become involved with and specialized in management of addictions, mental health and severe and chronic pain as well as general medicine. These are also all important aspects of cancer management. They are the areas of medicine that tend to be under-serviced by GPs due to time constraints or lack of training. But there is more that makes Dr Bruce Whelan uniquely suited to the new Health Intelligence Australia group.
Another area of Dr Bruce Whelan’s expertise is in the area of trauma. He knows a lot about trauma at a very personal level because in 2002 he was summoned to Bali from Sri Lanka, where he was working.  He was given the unspeakably grim task of identifying bodies after the bombing at the Sari Club in Bali. His task was made even worse when he spent two days unsuccessfully trying to find and identify the body of his son-in-law Shane – killed in the bombing along with a partner of his daughter’s friend. As luck had it the girls were going to be late getting to the Sari Club that night. But lucky as they were to escape; the trauma of the incident lived on and shaped their future.
When Bruce graduated  from the University of Queensland in 1967, like many of us, he had no idea what life had in store for him. As a doctor, Bruce Whelan had already seen lot of suffering, but the post-traumatic stress affect that the Bali incident produced, had long lasting effects. The product of uninvited change!  Bruce fought a battle he could not win; to have bodies quickly identified, stored appropriately and repatriated to Australia.

Dr Bruce Whelan
Dr Bruce Whelan

This intensified the trauma, grief and loss experienced by many. However, being a resourceful doctor, eventually he was able to spin gold from straw as they say, and today, 14 years later; the experience brings with it a man who is the wounded healer who serves his patients with a rare quality of directness and authenticity. He is someone who deeply understands trauma and depression in another human being.

There is no substitute for this type of life experience. This type of experience can’t be learned in any university except in the university of life!
It is recognized by psycho-oncologists that a diagnosis of cancer is also a traumatic event and many patients experience PTSD (post traumatic stress disorder) that often remains undiagnosed and untreated throughout the course of the illness. Some patients have experienced trauma before diagnosis and it may not have been dealt with. Unrecognized trauma can play a complicated role in the ongoing management of illness. Major life traumas can  impact every treatment approach that a cancer patient will try during their recovery….. it can even affect patients who are survivors of the physical illness, but who did not have the opportunity to deal with the psychological impact of the illness at the time.  This often plays out as depression, memory loss or dissociative disorders.
To make an appointment for a consultation to see either myself or Dr Whelan, or for a team consultation,  please visit:
RESOURCES:   Check out the following resources to understand more about PTSD and the brain:The Biology of Trauma           http://www.natal.org.il/english/?CategoryID=232
Article Psychology Today:   The Anatomy of Post traumatic Stress Disorder
Listen to interviews with Dr Bruce Whelan on Voice America – at http://www.drbrucewhelan.com/about-dr-bruce/

Promising Results from World-First Brain Cancer Trials Professor Rajiv Khanna | Grace Gawler on Navigating The Cancer Maze

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses. Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM).

Free informational cancer seminars Brisbane June 15 – 21 2014 Brisbane.

Click the link below to see other events presented by QIMR – for immunology week June 15 – 21 2014 Brisbane.

How your body can fight cancer Seminars

cancer-lambert_2469736bPromising Results from World-First Brain Cancer Trials Professor Rajiv Khanna Joins Grace Gawler on Navigating The Cancer Maze To Talk about a Brain Cancer breakthrough.

Phoenix, AZ — 06/13/2014 — Voice America Talk Radio Network, Internet broadcasting pioneer, producing and syndicating online audio and video, today announced that Professor Rajiv Khanna QIMR Berghofer Medical Research Institute Australia will join Grace Gawler host of Navigating the Cancer Maze program on the VoiceAmerica Health and Wellness Channel (http://www.voiceamerica.com/show/2125/navigating-the-cancer-maze) Friday, June 13, 2014 at 12 noon Pacific Time.

NOTE: show goes live to air 5 am Brisbane Australia time Saturday 14 June 2014. Available streaming audio any time after 9 am this Saturday and available to download on itunes indefinitely.

It is imperative that breakthroughs in cancer treatments are known to the world. Worldwide, there are an estimated 240,000 cases of brain and nervous system tumors diagnosed each year; GBM is the most common, and the most lethal of these tumors. People speak of the War on Cancer, but it is our bodies that are at war with cancer cells via our immune system and its responses.  Utilizing the immune system principle, scientists at the QIMR Berghofer Medical Research Institute, Australia, have used immunotherapy to create a major breakthrough in the treatment of the brain cancer known as Glioblastoma Multiforme (GBM). Study leader, Professor Rajiv Khanna, said most of the study participants lived much longer than the six-month prognosis normally given to a patient with recurrent GBM, and some patients showed no signs of disease progression. “It is early days, but this is exciting,” Professor Khanna said.

“Survival rates for this aggressive cancer have barely changed in decades. There is an urgent clinical need for new treatments. “If this treatment can buy patients more time, then that is a big step forward.”

GBM
Image of Brain GBM

GBM is the most common malignant brain cancer, diagnosed in about 800 Australians every year.  Despite surgery, radiotherapy and chemotherapy, less than 10% of patients survive beyond five years. This study built on previous research which found that many brain tumours carry cytomegalovirus (CMV). About half of all Australians have the virus, but usually show no symptoms.

Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body.  When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said.

The QIMR is celebrating their research findings by hosting a series of immunology and cancer presentations between June 15 and June 21 in Brisbane. For those people who cannot attend, watch out on the websites for more information. www.qimrberghofer.edu.au   or  www.gracegawlermedia.com

The Phase I trials were conducted at Brisbane’s Wesley Hospital, under the leadership of neurosurgeon Professor David Walker.  “Working with patients with malignant brain tumors can be distressing, because we know so many will succumb,” Professor Walker said. “But this new branch of therapy lets us offer some hope that the future is going to be brighter, that new and innovative treatments mean things will hopefully improve in the future. “We have a long way to go, and there is hard work to be done, but we seem to be on the right track, and it is a pleasure to work with scientists at QIMR Berghofer to try to make a real difference.”

The research team is now keen to begin the next phase of trials, involving patients at an earlier stage of the cancer’s development. “These would be patients who have just been diagnosed and are about to start the standard treatments – surgery, then radiotherapy or chemotherapy.  We would generate the T cell therapy before their standard treatment, and then administer T cells in conjunction with the standard therapy,” Professor Khanna said.

“We hope that the treatment can be even more effective if given at an earlier stage of the disease.”

This study is published online in the prestigious US journal Cancer Research and can be viewed at http://cancerres.aacrjournals.org/content/early/recent

The research was funded by Flagship Funding from the Rio Tinto Ride to Conquer Cancer, the NHMRC and private donors.

The QIMR Berghofer Medical Research Institute is a world leading translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Working in close collaboration with clinicians and other research institutes, our aim is to improve health by developing new diagnostics, better treatments and prevention strategies.

For more information about QIMR Berghofer Visit: www.qimrberghofer.edu.au

Immunology and Cancer Survival | Navigating the Cancer Maze| Grace Gawler

QIMR Berghofer Medical Research Institute is hosting Immunotherapy week: Get updated about Immunotherapies. Next week QIMR presents a series of lectures about the latest developments in Cancer Immune therapies. QIMR’s Professor Khanna, has been researching immunotherapies and has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM).

ATTENTION Queenslanders interested in immune-based Cancer Therapies:  Cancer Immunotherapy Week Brisbane

QIMR Berghofer Medical Research Institute is hosting Immunotherapy week: Get updated about Immunotherapies. Next week QIMR presents a series of lectures about the latest developments in Cancer Immune therapies.

Scientists at the QIMR Berghofer Medical Research Institute have used immunotherapy to make a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). There will be a presentation on Tuesday evening and other presentations throughout the week.

CLICK HERE FOR MORE INFORMATION

QIMR IMMUNOTHERAPY WEEK
Later this week on Navigating the Cancer Maze I will be interviewing…Professor Rajiv Khanna a leading researcher at The QIMR Berghofer Medical Research Institute, Brisbane, Australia; a world progressive translational research institute focused on cancer, infectious diseases, mental health and a range of complex diseases. Professor Khanna has been researching immunotherapies and has had a major breakthrough in the treatment of the aggressive brain cancer Glioblastoma Multiforme (GBM). Professor Khanna developed a technique to modify the patients’ T-cells in the laboratory, effectively “train” them to attack the virus, and then return them to the patient’s body.  When the killer T-cells destroyed the virus, they also destroyed the cancer. “It’s becoming increasingly clear that immunotherapy – manipulating a person’s own immune system – is a rich new frontier for cancer treatment,” Professor Khanna said. Be informed about the answer to cancer. Support Immunotherapy week- Brisbane Qld. More info at http://www.qimrberghofer.edu.au/

All shows are available in the content Library at Navigating the Cancer Maze on The VoiceAmerica Variety Channel for on-demand and pod cast download. The Grace Gawler Institute is a not for profit health promotion charity providing global access to free information for cancer patients about the latest in cancer information and treatments from experts, patients, caregivers and researchers.

Visit:  http://www.gracegawlerinstitute.com

Why We Need to Search for the Truth in Cancer Cure Stories – Ovarian Cancer Help Part 3

Last week on Navigating the Cancer Maze on Voice America Health and Wellness Channel, I mentioned a immune treatment that is being acclaimed as a value add therapy for many cancer patients – in particular, those dealing with ovarian Cancer…

 Last week on Navigating the Cancer Maze on Voice America Health and Wellness Channel, I mentioned a immune treatment that is being acclaimed as a value add therapy for many cancer patients – in particular, those dealing with ovarian Cancer…

The links and information follows:DENVAXTM – DENDRITIC CELL THERAPY – Customized Cell-based Cancer Immunotherapy INSTITUTE OF CELLULAR THERAPIES ( source )

ovarian cancer
Ovarian Cancer – Dendritic cell vaccine shows promise

Ovarian cancer: A 58 yr old lady was diagnosed of cancer ovary in June 2004. Her CA 125 antigen marker was positive and in the range of 10,000 units. She was operated upon and given six cycles of chemotherapy. She recovered from her disease and her marker was also within normal range.  After one year, the CA 125 began rising and she presented to us with an increased titre of 400 units. There were signs of recurrence, and she opted for DC (DENVAX) therapy in June 2005. She has completed three years of receiving DENVAX. She is free of disease, proven both clinically and by radiological examinations. Her CA 125 marker is also stable for the last three years.

http://www.dendriticcellresearch.com/success_stories
http://www.dendriticcellresearch.com/publications

CUSTOMIZED DENDRITIC CELL IMMUNOTHERAPY IN CANCER

Another treatment greatly assisting Ovarian cancer patients is used by Hallwang Private Oncology Clinic in Germany. Removab – a trifunctional antibody has been used at the Clinic for many years Click Here for information


Last week I also discussed
a new book by controversial American Cancer Physician Dr David Agus. His latest book A Short Guide to a Long Life by David B. Agus, MD, is published by Simon & Schuster ($24.99) and available on Amazon.

In his #1 New York Times bestselling book, The End of Illness, Dr. David B. Agus shared what he has learned from his work as a pioneering cancer doctor and researcher, revealing the innovative steps he takes to prolong the lives of not only cancer patients but all those hoping to enjoy a vigorous, lengthy life.

Now Dr. Agus has turned his analysis into a practical and concise illus­trated handbook for everyday living. He believes optimal health begins with our daily habits.

In A Short Guide to a Long Life, David Agus espouses the idea that prolonged good health starts with lots of smallish changes today. Much of the advice – don’t skip breakfast; avoid sunburn – will be familiar. He notes that Hippocrates made many of the same observations – “Walking is man’s best friend”; “Let food be thy medicine and medicine be thy food” – in the 4th century BC. Yet the truth is that few of us have so far incorporated them into our lives.

Some of Agus’s rules are cute: for instance, “Smile – the act itself will trigger the release of pain-killing, brain-happy endorphins and serotonin.” Others seem quirky – he’s adamantly against high heels: they cause inflammation, which can raise your lifetime risk of heart attack, strokes and cancer, he says.
A few of his dictums will give pause for uncomfortable thought. Rule 56 says to avoid airport backscatter X-ray scanners. Until science can prove they’re safe, Agus says, “I’ll be requesting the manual pat-down massage when I go through airports. You should, too.”
He debunks fads: rule 60 is “No Juicing”. “Does the body really like consuming 10 carrots all at once? Or a pound of radishes? I think not.” Or how about “Eat real food”. That means avoiding anything in a packet. It doesn’t matter if it announces itself to be good for you somehow by being, say, “cholesterol free” or “antioxidant rich”. “If they have to tell you why you should be eating it, you shouldn’t be eating it.”
In the book, Agus’s voice is calm and reassuring. In person, it’s more urgent. At one point he asks me if I’ve had a flu shot this year. I haven’t. “You should get it now,” he says. “If you get the flu, in a decade from now your chance of cancer or heart disease is elevated … So go and get that flu shot if you want to play with those grandkids. It’s a sore arm.”
Like most cancer doctors he sees the advanced disease; what can’t be reversed.   He wants to instil a new way of thinking about cancer. It’s not something that visits us from outside, he says. We don’t “get” cancer. Rather, we need to stop our bodies from “cancering”. Cancer is a verb, not a noun.
Some rules for living longer – A Short Guide to a Long Life by David B. Agus, MD

Caffeine, especially from traditional sources, may have protective, anti-cancer properties. But moderation is key.
Smiling triggers the release of pain-killing, brain-happy endorphins and serotonin.
Uncomfortable shoes cause inflammation that can have an impact on your entire system … Inflammation has been linked to heart disease, Alzheimer’s, cancer, autoimmune diseases and diabetes.
– Track your movement during the day with an accelerometer, and develop a daily personal activity target. Being sedentary is about as bad for you as smoking.
Cleanliness counts. Wash your hands regularly, especially after exposure to germy things such as bathrooms.
To reap the benefits of exercise, including all those biochemical reactions that lower your risk of illness, aim to break a sweat and get your heart pumping fast for a minimum of 15 minutes a day.
Moderate alcohol intake, especially from red wine, can reduce one’s risk of heart disease. This benefit does have a caveat: drinking can potentially increase one’s risk for breast cancer, and drinking too much is far worse for your heart than being a teetotaller. Agus has a glass of red a day.
Cold-water fish, such as salmon, sardines, tuna, trout, anchovies, herring, halibut, cod, black cod, mackerel and mahi-mahi are excellent sources of high-quality protein, healthy fats and naturally occurring vitamins and minerals.
A daily low-dose aspirin (75mg) has been shown to reduce the risk of developing common malignant cancers in the lungs, colon and prostate by 46 per cent. So if you’re basking in the glory of middle age, this is something to discuss with your doctor. It’s the cheapest fountain of youth around and requires no prescription.  Read the article about Dr David Agus in the Australian Good Weekend Magazine

 Voice America Grace Gawler

 

Voice America|Caryle Hirshberg talks about her published Research on Spontaneous Remissions and Why people Heal| Grace Gawler

Navigating the Cancer Maze with Grace Gawler on Voice America. I interview the co author of Spontaneous Remission, a research compilation that launched Caryle Hirshberg into the cancer spotlight when it was published in 1993 by the institute of Noetic Sciences (IONS). Co authored by the late Brendan O’Regan; the book filled a gap in research as before that time there was no standard reference for the field of spontaneous remission. It is inspiring, educative and the only published Masterpiece that has dared to research this fascinating subject.

Today on Navigating the Cancer Maze
The book, Spontaneous Remission
, launched Caryle Hirshberg into the cancer spotlight when it was published in 1993 by the institute of Noetic Sciences (IONS). Co authored by the late Brendan O’Regan; the book filled a gap in research as before that time there was no standard reference for the field of spontaneous remission.

Spontaneous Remission Hirshberg &  ORegan
The book Spontaneous Remission – PDF downloads available see link below

 The Remission Project charter at IONS was to catalogue the world’s medical literature on the subject. The result was an assembly of the largest database of medically reported cases of spontaneous remission in the world, with more than 3,500 references from more than 800 journals in 20 different languages.

Another book followed; Remarkable Recovery which in 1994 the New York Times Literary Guild Book Club named as one of three of the hottest books on the horizon. Can we go beyond the stories and apply science to the study of remarkable recoveries? This week listen to Caryle Hirshberg answer this question and hear about her life’s work studying why people heal? To listen to Caryle’s interview with me, Grace Gawler  CLICK HERE

Caryle Hirshberg is a former Senior Research Associate with the Institute of Noetic Sciences she co authored Spontaneous Remission with Brendan O’Regan published in 1993. She has been involved with beneficial plant research and the Center for Integrative Medicine which researches globally, promoting pharmacological research and intelligent scientific approaches to studying into indigenous and traditional remedies. Caryle was senior Researcher for the six part documentary The Heart of Healing which became a signature series for investigation into the mystery of why people heal.

Caryle Hirshberg
Caryle Hirshberg

In an extraordinary career, Caryle’s undergraduate study was in chemistry, mathematics and psychology at University of Florida. Her graduate work was in neurochemistry at Indiana University.

She has been involved in researching remission, neurochemistry, pharmacology, cancer biochemistry and cardiology. She has lectured widely on the subject of spontaneous remissions.

Today she is private practice. CLICK HERE to listen to this INSPIRING interview:

TO VIEW SPONTANEOUS REMISSIONS FOR  FREE – SEE CHAPTERS AT THE FOLLOWING LINK.

http://noetic.org/library/publication-books/spontaneous-remission-annotated-bibliography/

You can download Chapters in PDF. There are some valuable and fascinating chapters on infection related remissions and a chapter on understanding of the mechanisms of cancer healing, is elegantly explained.  INSPIRING & HIGHLY RECOMMENDED.

This blog and Our Voice America Radio show – “Navigating the Cancer Maze” is a created as a public service by the Grace Gawler Institute for Integrated Cancer Solutions to enhance cancer education via valid and evidence based experience to help cancer patients and families make informed decisions. We are a not for profit health promotion charity with a Global impact.

www.gracegawlerinstitute.com   www.germancancertreatments.com